Abstract: |
Purpose Prone-position breast radiotherapy (RT) has been described as an alternative technique to improve dose homogeneity for women with large, pendulous breasts. We report the feasibility and dosimetric analysis of a simplified intensity-modulated RT (IMRT) technique, previously reported for women in the supine treatment position, to plan prone-position RT to the intact breast. Methods and materials Twenty patients with clinical Stage TisN0-T1bN1 breast cancer undergoing breast-conserving therapy underwent whole breast RT using a prone position technique. The treatment plans were developed using both conventional tangents and a simplified intensity-modulated tangential beam technique based on optimization of the intensity distributions across the breast. The plans were compared with regard to the dose-volume parameters. Results Dose heterogeneity within the breast planning target volume was significantly greater for the conventional tangent plans. Of 20 patients, 16 (80%) received maximal doses of ≥110% using the conventional tangents vs. only 1 (5%) using the IMRT plan. The isodose level encompassing 5% of the planning target volume was reduced from an average of 110% with conventional tangents to 105% with IMRT. The maximal dose within the planning target volume was reduced from an average of 114% with conventional tangents to 107% with IMRT. The greatest improvement was seen in the patients with the most pendulous breasts. Conclusion An IMRT planning approach is feasible for prone-position breast RT and improves dose homogeneity, particularly in women with larger, pendulous breasts. Additional follow-up is necessary to determine whether the improvements in dose homogeneity impact acute toxicity and cosmetic outcome in this cohort of women who have historically suffered from poor cosmesis after breast-conserving therapy. © 2004 Elsevier Inc. |
Keywords: |
adult; cancer chemotherapy; clinical article; controlled study; aged; middle aged; intensity modulated radiation therapy; doxorubicin; fluorouracil; paclitaxel; cancer radiotherapy; methotrexate; cancer staging; breast cancer; radiotherapy dosage; radiotherapy; cyclophosphamide; breast neoplasms; oncology; risk assessment; health care; intensity-modulated radiotherapy; tumors; feasibility studies; radiation oncology; dosimetry; radiotherapy, conformal; patient treatment; body posture; posture; carcinoma, intraductal, noninfiltrating; carcinoma, ductal, breast; drug dosage; supine position; humans; human; female; priority journal; article; prone breast radiotherapy; breast-conserving therapy (bct)
|